Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003116169 | SCV003789361 | uncertain significance | not provided | 2023-09-09 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 3931 of the FAT2 protein (p.Thr3931Met). This variant is present in population databases (rs140427755, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with FAT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 2421867). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV003143587 | SCV003833959 | uncertain significance | Spinocerebellar ataxia 45 | 2022-06-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004245933 | SCV004069628 | uncertain significance | not specified | 2023-06-22 | criteria provided, single submitter | clinical testing | The c.11792C>T (p.T3931M) alteration is located in exon 20 (coding exon 20) of the FAT2 gene. This alteration results from a C to T substitution at nucleotide position 11792, causing the threonine (T) at amino acid position 3931 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |